Cooper Companies | COO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
AtriCure USD 1.37M 42K 2025-12
Avanos Medical USD 1.9M 100K 2025-12
Bausch Health Companies USD 397M 15M 2025-12
Baxter International USD 58M 14M 2025-09
Bayer EUR 675M 87M 2025-12
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 20.9M 1.5M 2026-03
Dentsply International USD 24M 2M 2026-03
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 5.44B 5.44B 2026-03
Haemonetics USD 7.4M 190K 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 6.53M 162K 2026-03
Novartis USD 281M 8M 2025-09
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 46.29B 45.68B 2026-03
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03